Bio-Techne (TECH) EBIT Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) EBIT Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn -303.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -303.00
Dec 31, 2025 -659.00
Sep 30, 2025 -279,922.00
Jun 30, 2025 -3,548.00
Mar 31, 2025 -1,891.00
Dec 31, 2024 -719.00
Sep 30, 2024 -1,072.00
Jun 30, 2024 -1,151.00
Mar 31, 2024 -610.00
Dec 31, 2023 -880.00
Sep 30, 2023 -387.00
Jun 30, 2023 901.00
Mar 31, 2023 272.00
Dec 31, 2022 500.00
Sep 30, 2022 279,766.00
Jun 30, 2022 538.00
Mar 31, 2022 730.00
Dec 31, 2021 390.00
Sep 30, 2021 872.00
Jun 30, 2021 267.00